Odyssey Therapeutics, Inc. ODTX
Set alert
21.08 USD +1.55 +7.94%
As of Nov 3, 12:25 PM ET
19.70 Day range 21.61
15.10 52-week range 29.05
- YTD
- +28.38%
- 1 year
- +28.38%
- Open
- 19.72
- Prev close
- 19.53
- Mkt cap
- 1.01B
- Vol
- 128.66K
- Avg vol
- 263.69K
- EPS
- -7.55
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 19.70
- High
- 21.61
- Forward P/E
- -4.78
- Beta
- 0.00
- Short ratio
- 11.58
- Inst. own
- 83.08%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 22.53
- 200-d avg
- 19.92
- 1y target
- 35.75
3M chart
Events in this range
- Aug 4, 2026Earnings: -1.74; estimate -1.61; surprise -8.07%
- Aug 7, 2026Rating: JP Morgan · Overweight → Overweight
- Aug 27, 2026Rating: HC Wainwright & Co. · — → Buy
Signals (16)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Nov 2, 2026 | 1 day ago |
| SMA: Bearish | Oct 30, 2026 | 4 days ago |
| SMA: Bullish | Oct 29, 2026 | 5 days ago |
| MACD: Buy Signal | Oct 20, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| SMA: Bullish | Sep 29, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Sep 21, 2026 | 1 month ago |
| SMA: Bullish | Sep 18, 2026 | 1 month ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 9, 2026 | 1 month ago |
| RSI: Overbought | Sep 4, 2026 | 2 months ago |
| MACD: Buy Signal | Sep 2, 2026 | 2 months ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| RSI: Overbought | Aug 25, 2026 | 2 months ago |
| RSI: Overbought | Aug 20, 2026 | 2 months ago |
Analyst view
Price target (mean) 35.75 +69.6% upside
Now 21.08
- Target (low)
- 29.00
- Target (mean)
- 35.75
- Target (high)
- 44.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.93023 | -1.07 – -0.81 | 0.00 | 0.0% | 0 | 0.0% | 3 |
| Next quarter | -1.01 | -1.17 – -0.85 | 0.00 | 0.0% | 0 | 0.0% | 3 |
| Current year | -4.26 | -4.55 – -3.89 | 0.00 | 0.0% | 0 | 0.0% | 3 |
| Next year | -4.36 | -5.08 – -3.45 | -4.26 | -2.5% | 0 | 0.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 27, 2026 | HC Wainwright & Co. | Initiated | — | Buy |
| Aug 7, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jun 18, 2026 | Oppenheimer | Reiterated | Outperform | Outperform |
| Jun 2, 2026 | Cantor Fitzgerald | Initiated | — | Overweight |
| Jun 2, 2026 | TD Cowen | Initiated | — | Buy |
| Jun 2, 2026 | Wedbush | Initiated | — | Outperform |
| Jun 2, 2026 | JP Morgan | Initiated | — | Overweight |
| Jun 2, 2026 | Oppenheimer | Initiated | — | Outperform |